Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ)
CNY 18.76
(-0.74%)
CNY 18.76
(-0.74%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 74.92 Million CNY | -98.22% |
| 2022 | 4.2 Billion CNY | 197.79% |
| 2021 | 1.41 Billion CNY | 201.37% |
| 2020 | 468.92 Million CNY | 1029.24% |
| 2019 | 41.52 Million CNY | -32.39% |
| 2018 | 61.41 Million CNY | -6.22% |
| 2017 | 65.49 Million CNY | 9.72% |
| 2016 | 59.69 Million CNY | 67.69% |
| 2015 | 35.59 Million CNY | 65.26% |
| 2014 | 21.53 Million CNY | 194.17% |
| 2013 | 7.32 Million CNY | 422.31% |
| 2012 | 1.4 Million CNY | 453.58% |
| 2011 | 253.23 Thousand CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 32.05 Million CNY | 145.55% |
| 2024 Q2 | 33.11 Million CNY | 3.3% |
| 2024 Q3 | 15.77 Million CNY | -52.35% |
| 2023 Q3 | 32.72 Million CNY | -11.84% |
| 2023 Q4 | -70.37 Million CNY | -315.03% |
| 2023 FY | 74.92 Million CNY | -98.22% |
| 2023 Q1 | 75.45 Million CNY | -79.61% |
| 2023 Q2 | 37.12 Million CNY | -50.8% |
| 2022 Q4 | 370.03 Million CNY | -65.67% |
| 2022 Q2 | 1.37 Billion CNY | -1.27% |
| 2022 Q1 | 1.38 Billion CNY | 240.63% |
| 2022 FY | 4.2 Billion CNY | 197.79% |
| 2022 Q3 | 1.07 Billion CNY | -21.39% |
| 2021 Q1 | 341.24 Million CNY | 202.8% |
| 2021 Q3 | 425.87 Million CNY | 78.7% |
| 2021 Q2 | 238.31 Million CNY | -30.16% |
| 2021 Q4 | 407.78 Million CNY | -4.25% |
| 2021 FY | 1.41 Billion CNY | 201.37% |
| 2020 Q2 | 198.22 Million CNY | 10093.98% |
| 2020 Q4 | 112.69 Million CNY | -27.79% |
| 2020 FY | 468.92 Million CNY | 1029.24% |
| 2020 Q1 | 1.94 Million CNY | 159.77% |
| 2020 Q3 | 156.06 Million CNY | -21.27% |
| 2019 Q2 | 24.16 Million CNY | 50.14% |
| 2019 Q1 | 16.09 Million CNY | 19.98% |
| 2019 FY | 41.52 Million CNY | -32.39% |
| 2019 Q4 | -3.25 Million CNY | -171.99% |
| 2019 Q3 | 4.51 Million CNY | -81.3% |
| 2018 Q2 | 25.1 Million CNY | 84.31% |
| 2018 Q1 | 13.62 Million CNY | -27.94% |
| 2018 FY | 61.41 Million CNY | -6.22% |
| 2018 Q4 | 13.41 Million CNY | 44.64% |
| 2018 Q3 | 9.27 Million CNY | -63.06% |
| 2017 FY | 65.49 Million CNY | 9.72% |
| 2017 Q1 | 10.95 Million CNY | -25.15% |
| 2017 Q3 | 12.45 Million CNY | -46.27% |
| 2017 Q4 | 18.9 Million CNY | 51.78% |
| 2017 Q2 | 23.17 Million CNY | 111.61% |
| 2016 Q3 | 14.63 Million CNY | -3.79% |
| 2016 FY | 59.69 Million CNY | 67.69% |
| 2016 Q1 | 15.21 Million CNY | 73.8% |
| 2016 Q4 | 14.63 Million CNY | 0.0% |
| 2016 Q2 | 15.21 Million CNY | 0.0% |
| 2015 Q2 | 9.04 Million CNY | 0.0% |
| 2015 Q4 | 8.75 Million CNY | 0.0% |
| 2015 FY | 35.59 Million CNY | 65.26% |
| 2015 Q1 | 9.04 Million CNY | 42.71% |
| 2015 Q3 | 8.75 Million CNY | -3.25% |
| 2014 Q1 | 4.43 Million CNY | 56.87% |
| 2014 Q3 | 6.33 Million CNY | 43.05% |
| 2014 Q4 | 6.33 Million CNY | 0.0% |
| 2014 Q2 | 4.43 Million CNY | -0.0% |
| 2014 FY | 21.53 Million CNY | 194.17% |
| 2013 Q4 | 2.82 Million CNY | 0.0% |
| 2013 Q2 | 836.41 Thousand CNY | 0.0% |
| 2013 Q3 | 2.82 Million CNY | 237.71% |
| 2013 FY | 7.32 Million CNY | 422.31% |
| 2013 Q1 | 836.41 Thousand CNY | 0.0% |
| 2012 FY | 1.4 Million CNY | 453.58% |
| 2011 FY | 253.23 Thousand CNY | 0.0% |